Untitled Document
www.expresshealthcare.in INSIGHT INTO THE BUSINESS OF HEALTHCARE
January 2008  
Untitled Document
Sections

Market
Radiology Buzz
WeekEnd

Services
Subscribe/Renew
Archives/Search
Contact Us
Network Sites
Express Computer
CIO Decisions
Exp. Channel Business
Express Hospitality
Express TravelWorld
Express Pharma
Group Sites
ExpressIndia
Indian Express
Financial Express
Home - Market - Article

Stem Cells

Stem-cell patch may Fix Damaged Hearts

Scientists have made two significant advances in developing a stem-cell patch to repair the damage caused to the heart after an attack.

Sian Harding of London's Imperial College said recently that her team had successfully matured beating heart cells in a laboratory dish for up to seven months and developed a biocompatible scaffold to form the basis of a patch. The idea is to stitch or glue a patch of new tissue derived from embryonic stem cells over the damaged area of the heart to make the muscle viable again. During a heart attack or myocardial infarct, part of the heart muscle loses its blood supply and the oxygen-starved cells die, causing scarring.

"We really would like to cover the area of the infarct scar as much as possible, so it might be quite a large patch," Harding said, adding, "We think the patch itself will stop the scar expanding, which is one of the big problems when you have a myocardial infarction because the scar becomes weak and can bulge out."

The biomaterial developed for the patch is designed to have the same elasticity as heart muscle and can also be programmed to degrade safely in anything from two weeks upwards.

Several groups around the world are working on different ways to use stem cells in heart repair, but a key challenge is to get cells to function properly. By showing stem cell-derived heart cells can beat in a co-ordinated fashion for months on end, the Imperial team believes their patch should function smoothly alongside normal heart muscle, without causing abnormal heart rhythms.

Harding added that initial human trials of the patch could be underway within five years, after safety studies on animals and tests to see if the new cells are rejected.

Reuters

 


Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.